Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.15 +2.52%
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +6.1%
Financial Fact:
Gross Profit: 11.69M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.15 million.
GUIDANCE:
Harvard Bioscience sees Q1 2025 revenue of $19-21 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
- UBS Upgrades Challenger (CGF:AU) (CFIGY) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
